Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
BioLife Solutions, Inc. (NASDAQ: BLFS)
BLFS Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
8.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
-41.30%
BLFS Stock Analysis
BLFS
PE Ratio:
BLFS
PEG Ratio:
BLFS
Forward EPS Growth (12 month):
113.80%
BLFS
PS Ratio:
13.3
BLFS
PSG Ratio:
0.7
BLFS
Forward Revenue Growth (12 month):
18.10%
BLFS Articles
No data was found